In a study of patients with BRAF-mutant and BRAF-wild-type melanoma, BRAF-mutant tumors exhibited a higher degree of differential gene expression in comparison to BRAF-wild-type tumors of metastatic samples. This evidence concerns the gene BRAF and melanoma.